Exscientia is an AI-driven pharmatech company committed to discovering, designing and developing the best possible drugs in the fastest and most effective manner. Exscientia developed the first-ever functional precision oncology platform to successfully guide treatment selection and improve patient outcomes in a prospective interventional clinical study, as well as to progress AI-designed small molecules into the clinical setting.
Our pipeline demonstrates our ability to rapidly translate scientific concepts into precision-designed therapeutic candidates, with more than 25 projects underway. By designing better drugs, faster, we believe the best ideas of science can rapidly become the best medicines for patients.
Website: https://www.exscientia.ai/
Business Sector: Biotechnology
HQ Location: Oxford
Office Locations: Dundee , Osaka, Miami, Vienna, Cambridge and Boston
Number of Employees: 200
CEO: Andrew Hopkins
CTO: Garry Pairaudeau
Female Leadership:
Iva Navratilova: VP Biophysics
Amanda Galgay: VP Communications
Nazira Amra: VP Strategic Initiatives
Charlotte Deane: Chief Scientist Biologics AI
Cara Burnett: Executive Director, Talent Acquisition
Eileen Jennings-Brown - Chief Information Officer
All of our roles can be based in any of our offices or remotely. If you can't see the right role but would like to find out more about Exscientia, please get in touch. Click on our images to connect on LinkedIn.
Exscientia embraces equal opportunity and is committed to providing a diverse and inclusive community where everybody feels welcome. We welcome applications from all people regardless of background.
This website stores cookies on your computer. These cookies are used to improve your website and provide more personalized services to you, both on this website and through other media. To find out more about the cookies we use, see our Privacy Policy.
